Propuesta de uso de anakinra en el distrés respiratorio agudo secundario a COVID-19

Tang, 2020, Comparison of Hospitalized Patients with Acute Respiratory Distress Syndrome Caused by COVID-19 and H1N1, Chest, 10.1016/j.chest.2020.03.032 Meduri, 1995, Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time, Chest, 107, 1062, 10.1378/chest.107.4.1062 Meduri, 1995, Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome, Chest, 108, 1303, 10.1378/chest.108.5.1303 Dinarello, 2012, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, Nat Rev Drug Discov, 11, 633, 10.1038/nrd3800 Aranda-Valderrama, 2018, The Basic Science and Molecular Mechanisms of Lung Injury and Acute Respiratory Distress Syndrome, Int Anesthesiol Clin, 56, 1, 10.1097/AIA.0000000000000177 He, 2006, Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS, J Pathol, 210, 288, 10.1002/path.2067 Han, 2015, The acute respiratory distress syndrome: From mechanism to translation, J Immunol, 194, 855, 10.4049/jimmunol.1402513 Franchi, 2012, Sensing and reacting to microbes through the inflammasomes, Nat. Immunol, 13, 325, 10.1038/ni.2231 Grailer, 2014, Critical role for the NLRP3 inflammasome during acute lung injury, J Immunol, 192, 5974, 10.4049/jimmunol.1400368 Jones, 2014, The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury, Am J Respir Cell Mol Biol, 50, 270, 10.1165/rcmb.2013-0087OC Favero, 2017, Melatonin as an anti-Inflammatory Agent Modulating Inflammasome Activation, Int J Endocrinol, 2017, 1835195, 10.1155/2017/1835195 Dinarello, 2012, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, Nat Rev Drug Discov, 11, 633, 10.1038/nrd3800 Willingham, 2009, NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways, J Immunol, 183, 2008, 10.4049/jimmunol.0900138 Fleischmann, 2003, Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial, Arthritis Rheum, 48, 927, 10.1002/art.10870 Kacar, 2020, The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature, J Inflamm Res, 13, 141, 10.2147/JIR.S206204